Publications by authors named "Steven Swann"

Claim this Profile
D
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.
Justin D Dietrich, Kenton L Longenecker, Noel S Wilson, Christian Goess, Sanjay C Panchal, Steven L Swann

J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp character and an exquisite selectivity profile.
Simone V Bigi-Botterill, Anthony Ivetac, Erica L Bradshaw, Derek Cole, Douglas R Dougan, Steven Swann

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate.
Russell A Judge, Anil Vasudevan, Victoria E Scott, Gricelda H Simler, Steve D Pratt, Steven I Swann

Chembiochem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.
Tony S Gibson, Benjamin Johnson, Andrea Fanjul, Petro Halkowycz, Douglas R Dougan, Steven Swann

Bioorg Med Chem Lett· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-based drug discovery of potent and selective MKK3/6 inhibitors.
Mark Adams, Toshitake Kobayashi, J David Lawson, Morihisa Saitoh, Kenichiro Shimokawa, Steven Swann

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal, integrative therapies for the self-management of chronic pain symptoms.
Courtney Lee, Cindy Crawford, Steven Swann,

Pain Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
Andrew M Petros, Steven L Swann, Danying Song, Kerren Swinger, Chang Park

Bioorg Med Chem Lett· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unified, probabilistic framework for structure- and ligand-based virtual screening.
Steven L Swann, Scott P Brown, Steven W Muchmore, Hetal Patel, Philip Merta

J Med Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical and biophysical characterization of unique switch pocket inhibitors of p38α.
Steven L Swann, Philip J Merta, Lemma Kifle, Duncan Groebe, Kathy Sarris

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labeled Ligand Displacement: Extending NMR-Based Screening of Protein Targets.
Steven L Swann, Danying Song, Chaohong Sun, Philip J Hajduk, Andrew M Petros

ACS Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis